PCT Kronos AI forecast
A 30-trading-day price forecast for PureCycle Technologies Inc. Common stock (PCT) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts PureCycle Technologies Inc. Common stock at $6.37 on 2026-12-08, +113.8% from the last close of $2.98 on 2026-10-27. Eight out of ten sampled paths end between $5.80 and $6.69, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PCT
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $3.51 | $3.04 | $4.00 |
| 2026-11-10 | $3.70 | $2.39 | $4.71 |
| 2026-11-17 | $5.10 | $3.49 | $6.38 |
| 2026-11-24 | $5.68 | $4.73 | $6.66 |
| 2026-12-01 | $5.78 | $5.29 | $6.42 |
| 2026-12-08 | $6.37 | $5.80 | $6.69 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PCT?
- Kronos AI's median forecast for PCT is $6.37 in 30 trading days, +113.8% from the last close, with a 10–90% range of $5.80 to $6.69.
- Is the PCT Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LIN — Linde plc
- APD — Air Products and Chemicals Inc.
- DOW — Dow Inc.
- IFF — International Flavors & Fragrances Inc.
- LYB — LyondellBasell Industries NV
- DD — DuPont de Nemours Inc.